Associate Professor Mikala Egeblad is a recipient of the Marks Foundation Accelerating Scientific Platforms and Innovative Research (ASPIRE) award. The ASPIRE award funds high risk, high reward approaches to solving complex problems in cancer research that tend to fall outside the scope of other funding opportunities.
Egeblad’s research is aimed at untangling the connection between stress and metastatic cancer. This could lead to the development of drugs that prevent metastasis by interfering with the body’s stress response.
Xueyan He, a postdoctoral fellow in Egeblad lab who will be heading up the project, explained that uncovering the connection is crucial in the fight against cancer. “Patients get stressed when they receive a cancer diagnosis, we can’t prevent that,” He said. “So it is important to understand and learn to target stress-induced metastasis in order to prevent future spread.”